Pflug Koory’s AstraZeneca AZN Stock Holding History

Pflug Koory’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-34	Closed	-$3K	–	418
2018 Q3	$3K	Hold	34	–	–	﹤0.01%	389
2018 Q2	$2K	Hold	34	–	–	﹤0.01%	401
2018 Q1	$2K	Hold	34	–	–	﹤0.01%	392
2017 Q4	$2K	Hold	34	–	–	﹤0.01%	376
2017 Q3	$2K	Hold	34	–	–	﹤0.01%	382
2017 Q2	$2K	Hold	34	–	–	﹤0.01%	382
2017 Q1	$2K	Hold	34	–	–	﹤0.01%	378
2016 Q4	$2K	Buy	+34	New	+$1.93K	﹤0.01%	371

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Pflug Koory's AZN Position: Q4 2018 in Review

Pflug Koory sold out of AstraZeneca (AZN) in Q4 2018, closing a stake of 34 shares — an estimated $3K sold.

Pflug Koory first reported a position in AZN in Q4 2016 and held it in 8 quarters. The position peaked at $3K in Q3 2018. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

Pflug Koory reported no remaining AstraZeneca position as of Q4 2018 after selling out during the quarter.
Pflug Koory sold 34 AstraZeneca shares in Q4 2018, an estimated $3K.
Pflug Koory first reported a position in AstraZeneca in Q4 2016 and held it in 8 quarters.
Pflug Koory's AstraZeneca position peaked at $3K in Q3 2018.
557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on Pflug Koory's 13F filing for Q4 2018, filed 24 Jan 2019.